Literature DB >> 34150356

What about biomarkers for parkinson's disease?

Naga Krishnakanth Madireddy1, Dheeraj Kumar Posa1, Shivani Naik1, Steven Lippmann1.   

Abstract

Entities:  

Year:  2021        PMID： 34150356      PMCID： PMC8195565     

Source DB:  PubMed          Journal:  Innov Clin Neurosci        ISSN： 2158-8333


× No keyword cloud information.
  10 in total

Review 1.  Biochemical premotor biomarkers for Parkinson's disease.

Authors:  Brit Mollenhauer; Jing Zhang
Journal:  Mov Disord       Date:  2012-04-15       Impact factor: 10.338

2.  Dopamine transporter imaging is associated with long-term outcomes in Parkinson's disease.

Authors:  Bernard Ravina; Kenneth Marek; Shirley Eberly; David Oakes; Roger Kurlan; Alberto Ascherio; Flint Beal; James Beck; Emily Flagg; Wendy R Galpern; Jennifer Harman; Anthony E Lang; Michael Schwarzschild; Caroline Tanner; Ira Shoulson
Journal:  Mov Disord       Date:  2012-09-13       Impact factor: 10.338

3.  The current and projected economic burden of Parkinson's disease in the United States.

Authors:  Stacey L Kowal; Timothy M Dall; Ritashree Chakrabarti; Michael V Storm; Anjali Jain
Journal:  Mov Disord       Date:  2013-02-21       Impact factor: 10.338

4.  Detection of oligomeric forms of alpha-synuclein protein in human plasma as a potential biomarker for Parkinson's disease.

Authors:  Omar M A El-Agnaf; Sultan A Salem; Katerina E Paleologou; Martin D Curran; Mark J Gibson; Jennifer A Court; Michael G Schlossmacher; David Allsop
Journal:  FASEB J       Date:  2006-03       Impact factor: 5.191

Review 5.  Cerebrospinal fluid biomarkers in Parkinson disease.

Authors:  Lucilla Parnetti; Anna Castrioto; Davide Chiasserini; Emanuele Persichetti; Nicola Tambasco; Omar El-Agnaf; Paolo Calabresi
Journal:  Nat Rev Neurol       Date:  2013-02-19       Impact factor: 42.937

Review 6.  Preclinical biomarkers of Parkinson disease.

Authors:  Yuncheng Wu; Weidong Le; Joseph Jankovic
Journal:  Arch Neurol       Date:  2011-01

Review 7.  Parkinson disease, 10 years after its genetic revolution: multiple clues to a complex disorder.

Authors:  Christine Klein; Michael G Schlossmacher
Journal:  Neurology       Date:  2007-08-29       Impact factor: 9.910

8.  Accuracy of Parkinson's disease diagnosis in 610 general practice patients in the West of Scotland.

Authors:  Edward J Newman; Kieran Breen; Jim Patterson; Donald M Hadley; Katherine A Grosset; Donald G Grosset
Journal:  Mov Disord       Date:  2009-12-15       Impact factor: 10.338

9.  Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury.

Authors:  Daniela Berg; Wolfgang Roggendorf; Ute Schröder; Rüdiger Klein; Thomas Tatschner; Peter Benz; Oliver Tucha; Michael Preier; Klaus W Lange; Karlheinz Reiners; Manfred Gerlach; Georg Becker
Journal:  Arch Neurol       Date:  2002-06

10.  Dopamine transporter imaging using 99mTc-TRODAT-1 SPECT in Parkinson's disease.

Authors:  Edson Bor-Seng-Shu; Andre C Felicio; Pedro Braga-Neto; Ilza Rosa Batista; Wellingson Silva Paiva; Daniel Ciampi de Andrade; Manoel Jacobsen Teixeira; Luis Augusto Franco de Andrade; Orlando Graziani Povoas Barsottini; Ming Chi Shih; Rodrigo A Bressan; Henrique Ballalai Ferraz
Journal:  Med Sci Monit       Date:  2014-08-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.